MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-17-0001332
Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹92.63 Lakh
▲ 89% YoY
Net profit · FY 2024
₹1.82 Lakh
Net margin 2%
EBITDA · FY 2024
₹2.04 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Gladly Pharmaceuticals Private Limited
Data last updated:
Gladly Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 13 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2020PTC340601. Its GSTIN is 27AAICG3361K1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Kumar Mishra and Ranjana Santosh Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No D 012 Saileela Tower Vinnay Complex Nr Railway Yard, Thane, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹92.63 Lakh, a growth of 89% compared to the previous year. For the same year it recorded a net profit of ₹1.82 Lakh (net margin 2%) and EBITDA of ₹2.04 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 295% over three years.
Gladly Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0001332).
Company details
CIN U24110MH2020PTC340601
Registration Number 340601
Incorporation Date 13 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0001332
Recognitions & Rankings of Gladly Pharmaceuticals
Contact details
Gladly Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No D 012 Saileela Tower Vinnay Complex Nr Railway Yard, Thane, Maharashtra, India – 401203
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Gladly Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Gladly Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Gladly Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Gladly Pharmaceuticals Private Limited, buy the company report.
Financials of Gladly Pharmaceuticals Private Limited
FY 2025 filings availableGladly Pharmaceuticals Private Limited reported revenue of ₹92.63 Lakh (up 89% YoY) for FY 2024.
Revenue · FY 2024
₹92.63 Lakh ▲ 89%
Net profit · FY 2024
₹1.82 Lakh margin 2%
EBITDA · FY 2024
₹2.04 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 89%
3 years · compounded
▲ 295%
EBITDA CAGR growth
1 year
▲ 109%
3 years · compounded
▲ 180%
Revenue has grown at a compounded annual rate (CAGR) of 295% over three years, including 89% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.04 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.82 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.2% | |||
| Net Profit Margin | 2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Gladly Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Mishra | Director | 13 Jun 2020 | 6 Years 4 Months | Current |
| Ranjana Santosh Mishra | Director | 13 Jun 2020 | 6 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Gladly Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gladly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Gladly Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Gladly Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICG3361K1ZD | Maharashtra | Active | 30 Jun 2020 |
To see the full GST registrations and return filing status of Gladly Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gladly Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ranjana Santosh Mishra was appointed as Director on 13 Jun 2020.
AGM
Gladly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gladly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Ranjana Santosh Mishra was appointed as Director.
Appointed
Santosh Kumar Mishra was appointed as Director.
Incorporation
13 Jun 2020
Gladly Pharmaceuticals Private Limited was registered on 13 Jun 2020 with Roc Mumbai Ii & aged 6 years 4 months as per MCA records.
Frequently asked questions
Gladly Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 13 June 2020 (6+ years old) and is registered under CIN U24110MH2020PTC340601.
Gladly Pharmaceuticals has 2 current directors:
- Santosh Kumar Mishra - Director
- Ranjana Santosh Mishra - Director
The latest financial statements of Gladly Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Gladly Pharmaceuticals is 27AAICG3361K1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gladly Pharmaceuticals is U24110MH2020PTC340601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gladly Pharmaceuticals was incorporated on 13 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Ranjana Santosh Mishra was appointed as Director on 13 Jun 2020. Santosh Kumar Mishra was appointed as Director on 13 Jun 2020.
Yes, Gladly Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0001332).
The registered office of Gladly Pharmaceuticals is at Shop No D 012 Saileela Tower Vinnay Complex Nr Railway Yard, Thane, Maharashtra, India – 401203.
Gladly Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.